Robert E. Sobol - Concepedia

Author

Robert E. Sobol

University of California San Diego ORCID

Also Known As

R E SOBOL, R E Sobol, R SObol, R Sobol, R. E. Sobol, R.E. SOBOL, R.E. Sobol, ROBERT E. SOBOL, Robert E Sobol, Robert E. Sobol

Publications

2.3K

Citations

H-Index

Concepts

All Affiliations

University of California San Diego Sidney Kimmel Cancer Center Regional Cancer Center University of Toledo Medical Center Mary Crowley Cancer Research Center

About

Robert E. Sobol is an author at University of California San Diego specializing in medicine, pathology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	13	587
2	Cell Biology	5	5	209
3	Allergy	3	3	105
4	Engineering	1	1	18
5	Health Sciences	1	1	88

Robert E. Sobol

Publications

Citations

H-Index

Page 1

	Year	Citations
Eradication of established intracranial rat gliomas by transforming growth factor beta antisense gene therapy. Habib Fakhrai, Oliver Dorigo, Daniel L. Shawler, Proceedings of the National Academy of Sciences	1996	338
Clinical Importance of Myeloid Antigen Expression in Adult Acute Lymphoblastic Leukemia Robert E. Sobol, Rosemarie Mick, Ivor Royston, New England Journal of Medicine	1987	320
Interleukin-2 gene therapy in a patient with glioblastoma. Robert E. Sobol, Habib Fakhrai, Daniel L. Shawler, PubMed	1995	104
Immunotherapy of Advanced Malignancy by Direct Gene Transfer of an Interleukin-2 DNA/DMRIE/DOPE Lipid Complex: Phase I/II Experience Evanthia Galanis, E. M. Hersh, Alison Stopeck, Journal of Clinical Oncology	1999	99
Elevated Serum Chromogranin A Concentrations in Small-Cell Lung Carcinoma Robert E. Sobol Annals of Internal Medicine	1986	98
Use of wild‐type <i>p53</i> to achieve complete treatment sensitization of tumor cells expressing endogenous mutant p53 Ruth A. Gjerset, Sally Turla, Robert E. Sobol, Molecular Carcinogenesis	1995	98
Hormone-Negative, Chromogranin a-Positive Endocrine Tumors Robert E. Sobol, V A Memoli, Leonard J. Deftos New England Journal of Medicine Endocrine OncologyMedicineNeuroendocrine DisorderPathologyChromogranin A	1989	96
Biomarkers Predict<i>p53</i>Gene Therapy Efficacy in Recurrent Squamous Cell Carcinoma of the Head and Neck John Nemunaitis, Gary L. Clayman, Sanjiv S. Agarwala, Clinical Cancer Research	2009	94
Lack of radioimmunodetection and complications associated with monoclonal anticarcinoembryonic antigen antibody cross-reactivity with an antigen on circulating cells. Robert O. Dillman, J Beauregard, Robert E. Sobol, PubMed Moab InfusionCancer ImmunosurveillanceMedicineImmunologyTumor Immunity	1984	89
Radioimmunodetection of melanoma utilizing In-111 96.5 monoclonal antibody: a preliminary report. Samuel E. Halpern, Robert O. Dillman, Kathryn F. Witztum, Radiology Melanoma MetastasesImmunologyPathologyImmunotherapeuticsDermatology	1985	88

Page 1